Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2008 2
2013 1
2015 1
2018 1
2019 3
2020 7
2021 3
2022 6
2023 4
2024 3
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yuki takeda (1 results)?
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR.
Miyauchi E, Morita S, Nakamura A, Hosomi Y, Watanabe K, Ikeda S, Seike M, Fujita Y, Minato K, Ko R, Harada T, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group. Miyauchi E, et al. J Clin Oncol. 2022 Nov 1;40(31):3587-3592. doi: 10.1200/JCO.21.02911. Epub 2022 Aug 12. J Clin Oncol. 2022. PMID: 35960896 Free PMC article. Clinical Trial.
Prognostic impact of oligometastasis in older patients with extensive-stage small cell lung cancer.
Morinaga D, Hashimoto K, Asahina H, Tanaka H, Honjo O, Harada T, Yokouchi H, Kikuchi H, Shigaki R, Takashina T, Nakamura K, Kawai Y, Takahashi M, Kida R, Sukoh N, Ito K, Takahashi A, Hommura F, Ohhara Y, Furuta M, Konno S, Hosomi Y, Oizumi S. Morinaga D, et al. Respir Investig. 2025 May;63(3):373-382. doi: 10.1016/j.resinv.2025.03.008. Epub 2025 Mar 18. Respir Investig. 2025. PMID: 40107221
Efficacy of atezolizumab, bevacizumab, carboplatin, and paclitaxel for epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after tyrosine kinase inhibitor failure.
Yamaguchi Y, Shinno Y, Masuda K, Ariyasu R, Nosaki K, Hakozaki T, Tokito T, Nomura S, Nishio M, Goto K, Hosomi Y, Azuma K, Ohe Y. Yamaguchi Y, et al. Curr Probl Cancer. 2025 Jun;56:101200. doi: 10.1016/j.currproblcancer.2025.101200. Epub 2025 Apr 4. Curr Probl Cancer. 2025. PMID: 40184872
Japanese Clinical Practice Guideline for Diabetes 2019.
Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Araki E, et al. J Diabetes Investig. 2020 Jul;11(4):1020-1076. doi: 10.1111/jdi.13306. J Diabetes Investig. 2020. PMID: 33021749 Free PMC article. No abstract available.
Predicting Radiation-Induced Esophagitis in Locally Advanced NSCLC Using Baseline Clinical Factors: A Model From the Japan Lung Cancer Society Integrated Phase II-III Database.
Uehara Y, Watanabe K, Tamura J, Ozawa Y, Yomota M, Kishino K, Kobayashi T, Taguchi K, Murofushi KN, Oizumi S, Hotta K, Shimokawa T, Niho S, Sugawara S, Okamoto I, Yamamoto K, Yamamoto N, Hosomi Y. Uehara Y, et al. Clin Lung Cancer. 2026 Jun;27(5):87-95. doi: 10.1016/j.cllc.2026.04.009. Epub 2026 Apr 24. Clin Lung Cancer. 2026. PMID: 42173719
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407.
Sugawara S, Tanaka K, Imamura F, Yamamoto N, Nishio M, Okishio K, Hirashima T, Tanaka H, Fukuhara T, Nakahara Y, Kurata T, Katakami N, Okada M, Horinouchi H, Udagawa H, Kasahara K, Satouchi M, Saka H, Tokito T, Hosomi Y, Aoe K, Kishi K, Ohashi K, Yokoyama T, Adachi N, Noguchi K, Schwarzenberger P, Kato T. Sugawara S, et al. Cancer Sci. 2023 Aug;114(8):3330-3341. doi: 10.1111/cas.15816. Epub 2023 May 15. Cancer Sci. 2023. PMID: 37183528 Free PMC article. Clinical Trial.
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Tozuka T, Noro R, Mizutani H, Kurimoto F, Hakozaki T, Hisakane K, Naito T, Takahashi S, Taniuchi N, Yajima C, Hosomi Y, Hirose T, Minegishi Y, Okano T, Kamio K, Yamaguchi T, Seike M; East Japan Chesters Group. Tozuka T, et al. Lung Cancer. 2024 May;191:107540. doi: 10.1016/j.lungcan.2024.107540. Epub 2024 Mar 24. Lung Cancer. 2024. PMID: 38614069
Shorter door-to-balloon time, better long-term clinical outcomes in ST-segment elevation myocardial infarction patients: J-MINUET substudy.
Nishio R, Ogita M, Suwa S, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Fujimoto K, Dai K, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Wake M, Tanabe K, Shibata Y, Tsutsui H, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Oshima S, Yoshikawa Y, Ogata S, Nishimura K, Miyamoto Y, Ishihara M; J-MINUET investigators. Nishio R, et al. J Cardiol. 2023 Jun;81(6):564-570. doi: 10.1016/j.jjcc.2023.01.008. Epub 2023 Feb 2. J Cardiol. 2023. PMID: 36736534 Free article.
37 results